Edward A. Stadtmauer

Hospital of the University of Pennsylvania — United States

Medicine · Health Sciences

88h-index35.9kcitations627works10.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Myeloma Research and Treatments(274), Hematopoietic Stem Cell Transplantation(138), CAR-T cell therapy research(113), Protein Degradation and Inhibitors(80), Acute Myeloid Leukemia Research(74)

Publications626 total

Outcomes of radiation integrated with T-cell–engaging bispecific antibodies in relapsed/refractory multiple myeloma
Blood Advances·2025· 1 citedOpen Access
Supplementary Tables and Figures from Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy
2025Open Access
Outcomes of relapse after teclistamab therapy in multiple myeloma
Blood Cancer Journal·2025Open Access
Chimeric antigen receptor T-cell therapy in patients with coexisting malignancy and autoimmune disease
Blood·2025Open Access
Rebuilding immunity: Kinetics and clinical impact of immune reconstitution after CAR T-cell therapy in multiple myeloma
Blood·2025Open Access
CCR5 blockade: A therapeutic approach to uncouple CART-BCMA expansion from CART-mediated immune toxicities.
Blood·2025Open Access
Phase 2 study of cevostamab consolidation following BCMA CAR T cell therapy:  preliminary safety, efficacy, and correlative data from the “STEM” (Sequential T Cell-Engagement for Myeloma) trial
Blood·2025
Interim analysis of LimiTec, a prospective trial of limited-duration teclistamab for relapsed/refractory multiple myeloma
Blood·2025· 1 citedOpen Access
Fried's frailty phenotype predicts survival in pts with relapsed/refractory lymphoma or myeloma undergoing chimeric antigen receptor T-cell therapy – a prospective, observational Study
Blood·2025Open Access
Delayed neurotoxicity, enterocolitis, and BCMA-CART-associated immune-related adverse events (CirAE)  are caused by CD4+ CAR T-cells
Blood·2025
Outcomes of Radiation Therapy Integrated with T-cell Engaging Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma
Clinical Lymphoma Myeloma & Leukemia·2025
Phase 2 Study of Cevostamab Consolidation Following BCMA CAR T Cell Therapy: Preliminary Safety and Efficacy Data from the “STEM” (Sequential T Cell-Engagement for Myeloma) Trial
Clinical Lymphoma Myeloma & Leukemia·2025
Consolidative Use of BCMA CAR-T Therapy in Relapsed/Refractory Myeloma — A Retrospective Evaluation
Clinical Lymphoma Myeloma & Leukemia·2025
Clinical Outcomes after Teclistamab Failure in Relapsed/Refractory Multiple Myeloma
Clinical Lymphoma Myeloma & Leukemia·2025· 1 cited
CD4+ T-Cells Mediate Immune-Related Adverse Events (CirAE) Following BCMA CAR-T Therapy
Clinical Lymphoma Myeloma & Leukemia·2025
Access and outcomes of racial and ethnic minority populations receiving commercial anti-BCMA CART for myeloma
Blood Immunology & Cellular Therapy·2025· 3 citedOpen Access
Age-related disparities in treatment and outcomes for newly diagnosed multiple myeloma: a population-based study
Haematologica·2025Open Access
Clinical activity of novel targeting of S100A9 with tasquinimod for relapsed and refractory multiple myeloma (RRMM).
Journal of Clinical Oncology·2025
Disease response at apheresis and association with long-term outcomes following CAR-T cells for relapsed/refractory multiple myeloma (RRMM).
Journal of Clinical Oncology·2025
PO-06-152 LONG TERM ARRHYTHMIA RISK AND CARDIOVASCULAR EVENTS IN HEMATOPOIETIC CELL TRANSPLANT SURVIVORS REVEAL LINQ CANCER REGISTRY (ARCHER): A PROSPECTIVE CLINICAL COHORT TRIAL
Heart Rhythm·2025Open Access
page 1 of 32Next →

Frequent Co-authors

Bruce L. Levine(13), Carl H. June(13), Dan T. Vogl(13), Adam D. Cohen(10), Sagar Lonial(9), Kenneth C. Anderson(9), Alfred L. Garfall(9), Paul G. Richardson(8), Pieter Sonneveld(7), Wei‐Ting Hwang(7), Brendan M. Weiss(7), David Porter(7), Jesús F. San Miguel(6), J. Joseph Melenhorst(6), Simon F. Lacey(6), Thierry Façon(5), Joan Bladé(5), Irina Kulikovskaya(5), Sergio Giralt(5), Aaron P. Rapoport(5)